Resumen de acción ALBERTDAVD
Albert David Limited fabrica y comercializa en la India fórmulas farmacéuticas, soluciones de infusión, formas farmacéuticas a base de plantas, medicamentos a granel y jeringuillas y agujas desechables.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Competidores de Albert David Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,192.45 |
| 52 Week High | ₹1,607.90 |
| 52 Week Low | ₹554.50 |
| Beta | 0.33 |
| 1 Month Change | 10.67% |
| 3 Month Change | -22.16% |
| 1 Year Change | 96.03% |
| 3 Year Change | 172.47% |
| 5 Year Change | 212.24% |
| Change since IPO | 281.89% |
Noticias y actualizaciones recientes
Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20
The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Recent updates
Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00
Jul 04Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00
May 22Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Rentabilidad de los accionistas
| ALBERTDAVD | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 6.0% | 2.3% | 2.6% |
| 1Y | 96.0% | 56.7% | 45.0% |
Rentabilidad vs. Industria: ALBERTDAVD superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 55.9% el año pasado.
Rentabilidad vs. Mercado: ALBERTDAVD superó al mercado Indian, que obtuvo un rendimiento del 46.4% el año pasado.
Volatilidad de los precios
| ALBERTDAVD volatility | |
|---|---|
| ALBERTDAVD Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: El precio de las acciones de ALBERTDAVD ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ALBERTDAVD (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1938 | 1,271 | Umesh Kunte | www.albertdavidindia.com |
Albert David Limited fabrica y comercializa en la India formulaciones farmacéuticas, soluciones de infusión, formas farmacéuticas a base de plantas, medicamentos a granel y jeringuillas y agujas desechables. Ofrece fórmulas parenterales, orales/entéricas, agentes tópicos y productos para el cuidado de la vista. La empresa exporta sus productos a países de América Latina, el Sudeste Asiático y otros países africanos.
Resumen de fundamentos de Albert David Limited
| Estadísticas fundamentales de ALBERTDAVD | |
|---|---|
| Capitalización bursátil | ₹6.80b |
| Beneficios(TTM) | ₹662.42m |
| Ingresos (TTM) | ₹3.55b |
10.3x
Ratio precio-beneficio (PE)1.9x
Ratio precio-ventas (PS)¿Está ALBERTDAVD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ALBERTDAVD | |
|---|---|
| Ingresos | ₹3.55b |
| Coste de los ingresos | ₹1.27b |
| Beneficio bruto | ₹2.28b |
| Otros gastos | ₹1.62b |
| Beneficios | ₹662.42m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 116.07 |
| Margen bruto | 64.33% |
| Margen de beneficio neto | 18.67% |
| Ratio deuda/patrimonio | 0.3% |
¿Cómo se ha desempeñado ALBERTDAVD a largo plazo?
Ver rendimiento histórico y comparativa